Affluent Partners Holdings AI Stock Analysis
Want to see HK:1466 full AI Analyst Report?
Affluent Partners Holdings (1466) AI Stock Analysis
Affluent Partners Holdings
(HKEX:1466)
The overall score is constrained primarily by a high-risk financial profile characterized by shrinking revenue, large losses, and persistent negative cash flow, despite a moderately leveraged balance sheet. Technical indicators show strong recent price strength but stretched momentum, adding short-term downside risk rather than offsetting the weak fundamentals. Valuation offers limited support given the negative P/E and absence of dividend yield data, reinforcing a cautious view on the stock.
Affluent Partners Holdings (1466) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 139.84M
- Dividend Yield
- ―
- Average Volume (3M)
- 2.10M
- Price to Earnings (P/E)
- -29.4
- Beta (1Y)
- -1.42
- Revenue Growth
- -34.12%
- EPS Growth
- -2893.33%
- Country
- Hong Kong
- Employees
- 84
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Luxury Goods
Affluent Partners Holdings Business Overview & Revenue Model
Company Description
Baijin Life Science Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including their acquisit...
Affluent Partners Holdings Financial Statement Overview
Summary
Revenue has recently declined sharply and profitability and cash generation are both very weak, with heavy losses and sustained negative operating and free cash flow partly offset by a moderately leveraged but equity-supported balance sheet.
Income Statement
18Very NegativeBalance Sheet
52NeutralCash Flow
22Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.30M | 89.30M | 135.56M | 53.68M | 86.88M | 62.65M |
| Gross Profit | 6.67M | 6.67M | 41.99M | 18.10M | 7.83M | 10.99M |
| EBITDA | -35.06M | -38.65M | 6.26M | -6.32M | 11.13M | -9.73M |
| Net Income | -37.87M | -37.87M | -316.00K | -7.45M | 8.73M | -15.46M |
Balance Sheet | ||||||
| Total Assets | 264.44M | 264.44M | 290.17M | 196.80M | 99.85M | 82.11M |
| Cash, Cash Equivalents and Short-Term Investments | 43.11M | 43.11M | 47.77M | 37.88M | 41.26M | 23.59M |
| Total Debt | 28.41M | 28.41M | 99.93M | 51.19M | 2.76M | 31.84M |
| Total Liabilities | 72.18M | 72.18M | 134.30M | 84.01M | 21.51M | 46.24M |
| Stockholders Equity | 185.19M | 185.19M | 139.28M | 96.31M | 78.34M | 35.87M |
Cash Flow | ||||||
| Free Cash Flow | -22.56M | -22.56M | -32.97M | -6.64M | -21.55M | 1.06M |
| Operating Cash Flow | -7.16M | -7.16M | -30.53M | -6.46M | -21.52M | 1.11M |
| Investing Cash Flow | -20.39M | -20.39M | -846.00K | 4.74M | 35.30M | -60.00K |
| Financing Cash Flow | 22.50M | 22.50M | 41.41M | 819.00K | 3.70M | -1.72M |
Affluent Partners Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1466, the sentiment is Positive. The current price of 1.65 is above the 20-day moving average (MA) of 1.61, above the 50-day MA of 1.55, and above the 200-day MA of 0.92, indicating a bullish trend. The MACD of 0.01 indicates Positive momentum. The RSI at 55.39 is Neutral, neither overbought nor oversold. The STOCH value of 69.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1466.
Affluent Partners Holdings Peers Comparison
Overall Rating
HK:088775Outperform
HK:039869.5Neutral
HK:338951Neutral- HK:146649Neutral
HK:025647Neutral
HK:185644Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:0887 | 75Outperform | HKD 1.89B | 3.35 | 9.96% | 7.70% | 8.83% | 109.28% |
| HK:0398 | 70Neutral | HKD 1.60B | 8.81 | 9.99% | 6.04% | -0.78% | -10.18% |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
| HK:3389 | 51Neutral | HKD 396.36M | -3.65 | -2.87% | 320.48% | -21.99% | -138.89% |
| HK:1466 | 49Neutral | HKD 1.51B | -29.41 | -23.23% | ― | -34.12% | -2893.33% |
| HK:0256 | 47Neutral | HKD 493.29M | -3.39 | -3.03% | ― | -4.85% | 60.69% |
| HK:1856 | 44Neutral | HKD 531.38M | -14.46 | -68.91% | ― | -8.88% | 42.89% |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1466 | Affluent Partners Holdings | 1.65 | 1.06 | 179.66% | |
| HK:0256 | Citychamp Watch & Jewellery Group | 0.09 | -0.08 | -44.97% | |
| HK:0887 | Emperor Watch & Jewellery | 0.27 | 0.01 | 5.58% | |
| HK:3389 | Hengdeli Holdings | 0.08 | 0.05 | 124.32% | |
| HK:0398 | Oriental Watch Holdings | 3.26 | 0.15 | 4.99% | |
| HK:1856 | Ernest Borel Holdings Ltd | 1.48 | -0.14 | -8.39% |
Affluent Partners Holdings Corporate Events
Baijin Life Science Wins Full Shareholder Backing at AGM
Shareholders of Baijin Life Science Holdings Limited unanimously approved all resolutions at the annual general meeting held on 16 September 2026. The meeting confirmed the company’s audited financial statements, re-elected four directors, renewed th...
Baijin Life Science Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
Baijin Life Science Holdings has convened its 2026 annual general meeting for mid-September in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 March 2026 and consider the re-election of four retiring d...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 30, 2026